Dooms, C A <br/><br/>
Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer.  [electronic resource] 

 -  The European respiratory journal  May 2006 
 - 895-901 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0903-1936 
<br/><br/><label>Standard No.: </label>10.1183/09031936.06.00102705  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--economics<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--economics<br/>Cost-Benefit Analysis<br/>Deoxycytidine--analogs & derivatives<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Vindesine--economics<br/>Gemcitabine